Inventor · disambiguated record
Enrique Zudaire
Also filed as: ZUDAIRE ENRIQUE
13 granted patents·4 pending applications·36 citations·filing 2008–2022
85Inventor score
Files withBIOMED VALLEY DISCOVERIES INC8US HEALTH4ZUDAIRE ENRIQUE2JANSSEN BIOTECH INC1JANSSEN PHARMACEUTICA NV1
Top patents by PatentIndex Score
17 records- 0196US9765142B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2014·Granted Sep 19, 2017·31 cites·49 claims
- 0286US10758614B2Combination therapies targeting tumor-associated stroma or tumor cells and topoisomeraseBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·3 cites·10 claims
- 0361US9186365B2Antiangiogenic small molecules and methods of useZUDAIRE ENRIQUE·Filed 2010·Granted Nov 17, 2015·1 cites·4 claims
- 0461US8679836B2Methods of monitoring angiogenesis and metastasis in three dimensional co-culturesZUDAIRE ENRIQUE·Filed 2010·Granted Mar 25, 2014·1 cites·20 claims
- 0560US10196443B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2017·Granted Feb 5, 2019·0 cites·33 claims
- 0653US2014155292A1Methods of monitoring angiogenesis and metastasis in three dimensional co-culturesUS HEALTH·Filed 2014·Application pending·0 cites
- 0752US2023277589A1Bcma-targeted car-t cell therapy for multiple myelomaJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0849US2022348662A1Use of fgfr inhibitors in fgfr-genetically altered cancers to enhance patient response to immune checkpoint inhibitors in sequential treatment settingsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0948US2009088341A1Multiplex assay method for mixed cell populationsUS GOV HEALTH & HUMAN SERV·Filed 2008·Application pending·0 cites
- 1045US10799584B2Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agentsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 13, 2020·0 cites·6 claims
- 1144US11033620B2Combination therapies targeting tumor-associated stroma or tumor cells and microtubulesBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·13 claims
- 1244US10758613B2Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 1344US9504729B2Antiangiogenic small molecules and methods of useUS HEALTH·Filed 2015·Granted Nov 29, 2016·0 cites·18 claims
- 1443US11034757B2Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculatureBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·6 claims
- 1542US10758526B2Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathwaysBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 1640US11033621B2Combination therapies targeting tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·12 claims
- 1739US10434174B2Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 8, 2019·0 cites·37 claims
Join the waitlist — get patent alerts
Get an alert when Enrique Zudaire files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →